News Detail
Kolkata, 27 Oct 2023: Low back pain (LBP) is a global health concern. Management of LBP aims at pain relief facilitating improvement of functional ability. Non-steroidal anti-inflammatory drugs (NSAIDs) are the first line of therapy. However, the selection of NSAIDs is challengin......
View Details
Source : Cureus
fixed-dose combination (fdc)
thiocolchicoside
randomized controlled trial (rct)
low back pain (lbp)
etoricoxib
Related News
- AI-Designed Antivenom Counteracts Toxins from Snakebites (17-01-2025)
- Researchers develop Quantum Dots that can help detect Antibiotics (17-01-2025)
- Feeding your good gut bacteria through fibre in diet may boost body against infections (13-01-2025)
- New combination drug offers treatment against intestinal worms: Lancet (13-01-2025)
- Researchers bypass the liver, delivering genetic drugs to the target location (01-01-2025)
- Study uses AI to cast light on harmful drug-drug interactions (16-12-2024)
- IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)
- Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)
- More than half of patients with rheumatic, musculoskeletal disease use OTC supplements: Study (18-11-2024)
- One-third of older people and individuals admitted to the hospital experienced ADRs: Study (17-11-2024)